The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study.
Stephen D SilbersteinJoshua M CohenMichael J SeminerioRonghua YangSait AshinaZaza KatsaravaPublished in: The journal of headache and pain (2020)
ClinicalTrials.gov NCT02621931 (HALO CM), registered December 12, 2012.